As of November 25 , Acalabrutinib has been approved as a mono therapy for second line treatment in France for patients not doing well on Ibrutinib.
My wife Gabriella had to stop Ibrutinib last January after a year because of muscle back pain and heavy bleeding and will resume treatment in the following days with this new drug .
I will keep you informed of her progress
Happy holidays and bless you all
Serge
Written by
Sergi
To view profiles and participate in discussions please or .
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.